Simple blood test could spot colon cancer early
NCT ID NCT07224789
First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study is testing a new blood test that looks for circular RNA, a genetic material, to detect colorectal cancer early. Researchers will collect blood samples from 600 adults with stage I-III colorectal cancer to see how accurately the test identifies the disease. If it works, this could lead to a non-invasive screening option that catches cancer sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cf-circRNA assay (blood test for circular RNA)
- What this could lead to
- If successful, this blood test could offer a simple, non-invasive way to catch colorectal cancer early, potentially improving survival rates.
- What could go wrong
- This is an early-stage study with 600 participants. The test may not be accurate enough for widespread use, and results need validation in larger, diverse populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?